Robinhood Just Leveled Up (But So Did the Risk for Retail)

Hello there.

Hundreds of investing and finance newsletters hit my (and maybe your) inbox every week. This is the best of the best of finance from last week. Friday, we’ll cover tech, and next Monday, we’ll tackle policy.

This week, we’ve got…

With how quickly the market and investment climate are changing right now, we can’t afford to fall behind. You can always read the latest and most relevant finance news & updates at FinanceWrapped.com.

And for daily deep dives covering everything from stocks and crypto to trade relations, AI investment signals, and more, subscribe to our daily newsletter Stocks & Income.

In partnership with Surf Lakes

Most companies chase one or two ways to make money. Surf Lakes has at least seven.

At the heart of it all is their patented 360° wave tech that creates 2,000 surfable rides per hour for beginners and pros alike. That single breakthrough unlocks multiple revenue streams: licensing fees, royalties, memberships, day passes, media, coaching, food, retail, and direct park operations.

It’s why surfing legends Tom Curren and Mark “Occy” Occhilupo are investing in the company.

Actor Chris Hemsworth even said this after his Surf Lakes experience: “What an incredible setup! Really thankful I got to test this out…an awesome day.”

Surf tourism is a $65B global industry, yet fewer than 1% of people can access real waves. Surf Lakes makes it possible anywhere, turning cities into surf destinations.

They’ve already sold nine licenses worldwide, and the expansion is coming. Back Surf Lakes by 9/12 and get up to 15% bonus shares.

Invest in Surf Lakes

_{This is a paid advertisement for Surf Lakes’ Regulation CF offering. Please read the offering circular at https://invest.surflakes.com}

Please support our partners!

Robinhood, the brokerage that became a household name during the meme stock craze, just got its official invitation to the big leagues. The company's stock is set to join the S&P 500, which means index funds will be forced buyers, and liquidity will surge. The brokerage is also launching short selling and multiple account ownership, which is only boosting its brand image (and its danger level for retail traders lol).

Speaking of Robinhood, Klarna’s IPO is today, and brokerage exchange users across the country are partaking in the beloved pastime of only getting 1 IPO share when they ordered 50+. If you ordered shares, we wish you luck.

Goldman Sachs’s top economist says the US economy is running close to "stall speed." We wish that had something to do with horse racing, but alas, it does not. He sees slow growth ahead until the Federal Reserve starts cutting rates, predicting three cuts before the year is out to get things moving again.

Big players are already repositioning. Goldman just announced a $1 billion investment in T. Rowe Price, a fast lane into retirement money that gives it access to a sticky client base.

However, the AI industry is moving as fast or faster than before: Oracle pumped 27% yesterday on insane cloud order book numbers (half a trillion dollars!), and $NBIS inked a $17 billy deal with Microsoft, sending shares up by 44%. What happens to AI stocks if rates are cut? You tell us.

In partnership with Surf Lakes

Uniswap web  app lets you swap thousands of tokens safely, in seconds. Open‑source, audited code and real‑time token warnings help keep you safe.

Get Started

Please support our partners!

A lot can happen in a week!

Let’s take a quick look at who struck gold and who struck out since our last issue:

Broadcom Inc. (AVGO): +14.48%
Alphabet Inc. (GOOG): +10.93%
Amazon.com, Inc. (AMZN): +3.18%
Meta Platforms, Inc. (META): +2.93%
Apple Inc. (AAPL): +1.62%

NVIDIA Corporation (NVDA): -3.70%
Berkshire Hathaway Inc. (BRK.A): -2.86%
Visa (V): -2.05%
JPMorgan Chase & Co. (JPM): -1.41%
Microsoft Corporation (MSFT): -1.35%

Analysis provided by ​altindex.com​.

Remember to always DYOR.

Vertex Pharmaceuticals is a global biotechnology company committed to developing transformative medicines for people with serious and life-threatening diseases. The company has been a leader in the cystic fibrosis (CF) treatment market and is renowned for its research and development efforts. Vertex is also expanding its pipeline to include therapies for other serious diseases, such as pain, sickle cell disease, and beta-thalassemia.

Current price: $390.92
Target price: $470.23

ResMed Inc. (RMD) specializes in the development, manufacturing, and marketing of products for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic diseases. ResMed operates globally, with its comprehensive portfolio including devices, cloud-connected software applications, and other healthcare solutions aimed at managing chronic diseases more effectively and economically.

The signals:

Current price: $267.27
Target price: $330.48

That’s all for today. Write us and let us know your thoughts on the market, the newsletter, or the weather—we’d just love to hear from you.

Till next time,
— Brandon and Blake of Invested Inc.